Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866))

Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866))

Bibliographic Details
Main Authors:	Noseworthy, J, Vandervoort, M, Ebers, G
Format:	Journal article
Language:	English
Published:	1990

Similar Items

PLASMA-EXCHANGE FOR MS
by: Noseworthy, J, et al.
Published: (1990)

Plasma exchange for MS.
by: Noseworthy, J, et al.
Published: (1990)

MS REFERENDUM - REPLY
by: Noseworthy, J, et al.
Published: (1990)

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
by: Noseworthy, J, et al.
Published: (1990)

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
by: Noseworthy, J, et al.
Published: (1989)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
by: Noseworthy, J, et al.
Published: (1989)

CYCLOPHOSPHAMIDE AND MS
by: Noseworthy, J, et al.
Published: (1994)

Cyclophosphamide and MS.
by: Noseworthy, J, et al.
Published: (1994)

A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
by: Noseworthy, J, et al.
Published: (1989)

INTERRATER VARIABILITY WITH THE EXPANDED DISABILITY STATUS SCALE (EDSS) AND FUNCTIONAL-SYSTEMS (FS) IN A MULTIPLE-SCLEROSIS CLINICAL-TRIAL
by: Noseworthy, J, et al.
Published: (1990)

EDSS RELIABILITY - REPLY
by: Noseworthy, J, et al.
Published: (1991)

Measuring disability progression in MS
by: Ebers, G, et al.
Published: (2005)

ESD.864 Modeling and Assessment for Policy, Spring 2011
by: Selin, Noelle
Published: (2011)

MULTIPLE-SCLEROSIS (MS) PRESENTING IN PATIENTS OVER 50 YEARS OF AGE
by: Noseworthy, J, et al.
Published: (1981)

12.864 Inference from Data and Models, Spring 2004
by: Wunsch, Carl
Published: (2004)

12.864 Inference from Data and Models, Spring 2003
by: Wunsch, Carl
Published: (2003)

Disability as an outcome in MS clinical trials.
by: Ebers, G, et al.
Published: (2008)

Acknowledgement to reviewers Metalurgija 55 (2016) 1-4, 1-864
by: I. Mamuzić
Published: (2017-01-01)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
by: Noseworthy, J, et al.
Published: (1994)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
by: Noseworthy, J, et al.
Published: (2001)

ESD.864 / ESD.936 Systems Modeling and Assessment for Policy, Spring 2010
by: Selin, Noelle
Published: (2010)

Impact of UCP2 -866G/A Variant on Smoking Risk
by: Ayşe Feyda NURSAL, et al.
Published: (2021-04-01)

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury
by: Esposito Emanuela, et al.
Published: (2012-04-01)

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.
by: Noseworthy, J, et al.
Published: (1993)

A search for strange quark matter in the -0.75T field setting of E864
by: Van Buren, Gene Edward, 1971-
Published: (2010)

The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
by: Kishor Pant, et al.
Published: (2023-02-01)

FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION
by: Noseworthy, J, et al.
Published: (1988)

Binary Fraction in Galactic Star Clusters: FSR 866, NGC 1960, and STOCK 2
by: L. Yalyalieva, et al.
Published: (2024-01-01)

Influencia del polimorfismo -866 G/A del gen de la UCP2 en población infantil obesa Influence of the -866G/A polymorphism of the UCP2 gene on an obese pediatric population
by: R. Zurbano, et al.
Published: (2006-02-01)

The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
by: Maxime Parisotto, et al.
Published: (2022-11-01)

Osler and neurology.
by: Ebers, G
Published: (1985)

OSLER AND NEUROLOGY
by: Ebers, G
Published: (1982)

Therapeutic Plasma Exchange - An Emerging Treatment Modality in Patients with Neurologic and Non-Neurologic Diseases
by: Shreedevi S Bobati, et al.
Published: (2017-08-01)

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
by: Noseworthy, J
Published: (1991)

Lower Cretaceous oolites from the Mid-Pacific Mountains (Resolution Guyot, Site 866)
by: Jenkyns, H, et al.
Published: (1995)

Molecular characterization, expression pattern and function analysis of the rice OsDUF866 family
by: Lihua Li, et al.
Published: (2017-03-01)

Therapeutic Plasma Exchange: An Indispensable Therapy for Severe Neurological Condition
by: Balasa Rodica
Published: (2020-05-01)

ACTIVE RELAPSING AND PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS HAVE SIMILAR MAGNETIC-RESONANCE-IMAGING BEHAVIOR - IMPLICATIONS FOR CLINICAL-TRIAL DESIGN
by: Noseworthy, J, et al.
Published: (1990)

الحرکة العلمیة فی طبرستان إبان الدولة العلویة (250-316هـ/864-928م)
by: محمد إسماعیل
Published: (2014-03-01)

The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
by: Goodin, D, et al.
Published: (1999)